The Role of Aspirin in Cardiovascular Prevention: Implications of Aspirin Resistance
Top Cited Papers
- 13 May 2008
- journal article
- review article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 51 (19), 1829-1843
- https://doi.org/10.1016/j.jacc.2007.11.080
Abstract
No abstract availableThis publication has 98 references indexed in Scilit:
- Prevalence of persistent platelet reactivity despite use of aspirin: A systematic reviewAmerican Heart Journal, 2007
- Multimedikation, Compliance und Zusatzmedikation bei Patienten mit kardiovaskulären ErkrankungenDeutsche Medizinische Wochenschrift (1946), 2007
- A multiple dose study of prasugrel (CS‐747), a novel thienopyridine P2Y12 inhibitor, compared with clopidogrel in healthy humansBritish Journal of Clinical Pharmacology, 2006
- Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic supportClinical Science, 2006
- Prevalence of aspirin resistance in patients with type 2 diabetesActa Diabetologica, 2005
- Screening for Aspirin Responsiveness After Transient Ischemic Attack and StrokeStroke, 2005
- The role of platelet glycoprotein IIIa polymorphism in the high prevalence of in vitro aspirin resistance in patients with intracoronary stent restenosisAmerican Heart Journal, 2005
- Biological Assessment of Aspirin Efficacy on Healthy IndividualsStroke, 2005
- The Warfarin/Aspirin study in heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failureAmerican Heart Journal, 2004
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002